Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy

Steven E. Coutre*, Megan Othus, Bayard Powell, Cheryl L. Willman, Wendy Stock, Elisabeth Paietta, Denise Levitan, Meir Wetzler, Eyal C. Attar, Jessica K. Altman, Steven D. Gore, Tracy Maher, Kenneth J. Kopecky, Martin S. Tallman, Richard A. Larson, Frederick R. Appelbaum

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences